Soranib 200mg tablet - Sorafenib Uses & Side effects
Soranib 200mg Tablet Sorafenib is pharmacologically categorized as protein kinase inhibitor, which is FDA approved compound used for the treatment of primary renal cell cancer in advanced stage, metastatic liver carcinoma (sorafenib liver cancer) and also involved in radioactive iodine resistant advanced thyroid cancer. Sorafenib is considered as synthetic compound aiming signal responding for growth and angiogenesis. Sorafenib works by blocking the enzyme RAF kinase, which is a demanding component of the RAF/MEK/ERK signaling pathway that dominates cell separation and multiplication. On the other hand, Sorafenib also prohibits the VEGFR-2/PDGFR-beta signaling force, through blockade of tumor angiogenesis. SORANIB (SORAFENIB) MECHANISM OF ACTION The activity of Soranib 200mg tablet containing Sorafenib is developing in-vitro. Soranib expels its activity by prohibiting assorted intracellular & cell surface kinase which is important for tumor cell signaling exudation, a...